Prostate cancer: brachytherapy tied to lower risk for radiation-induced cancers
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Low dose rate (LDR) and high dose rate (HDR) brachytherapy monotherapy resulted in low estimated risks for radiation-induced rectal and bladder cancer.
- LDR resulted in lower bladder cancer risks than HDR, and lower or similar risks of rectal cancer.
- Absolute excess risks for second rectal or bladder cancer were low for both LDR and HDR.
- Average excess absolute risks of rectal and bladder cancer for LDR brachytherapy were 0.71/10,000 person-years (PY) and 0.84/10,000 PY, respectively.
- For HDR, the average excess absolute risks for second rectal and bladder cancers were 0.74/10,000 PY and 1.62/10,000 PY, respectively.
- The absolute differences between techniques were clinically irrelevant.
- Compared with external beam radiotherapy, LDR and HDR brachytherapy resulted in the lowest risks for second rectal and bladder cancer.